[研究报告] 2022年流涎治疗市场价值为 6.9506 亿美元,预计到 2030 年将达到 10.4237 亿美元;预计 2022 年至 2030 年的复合年增长率为 5.2%。
市场洞察和分析师观点:
流涎症是指唾液分泌过多。当个体有大量唾液从气管后部漏出而不是正常吞咽时,这种情况被称为流涎症。患有前流涎症的患者会出现过多的前部或前部唾液分泌,也称为流口水,流到脸上和衣服上,这使他们难以保持卫生、护理皮肤和与他人互动。吸入是一种由此引起的长期肺部刺激,有时会导致肺炎。
增长动力和挑战:
患有神经系统疾病的患者患上慢性流涎症的几率更高。流涎症通常通过长期神经系统疾病引起的症状来治疗,这会增加患者的整体负担。患者的生理和心理负担会对他们的生活质量产生负面影响。患有脑瘫、帕金森病、中风或肌萎缩性脊髓侧索硬化症等神经系统疾病的人主要受慢性流涎症的影响。这些疾病会损害吞咽和唾液管理所需的肌肉协调能力。神经损伤或退化是肌萎缩性脊髓侧索硬化症或帕金森病的结果。大脑、唾液腺和吞咽肌是这些神经的主要信号转换器。信号中断、吞咽不良和唾液腺协调不良都是由损伤引起的。根据《临床神经科学杂志》发表的一篇文章,2019 年,约 40% 的脑瘫儿童和 80% 的帕金森病成年人患有流涎症。上述因素推动了流涎治疗市场的增长。
药物治疗的副作用包括药物的中枢作用引起的刺激、不安、镇静和谵妄。胃肠道 (GI) 运动的抑制导致已经饱受便秘困扰的人群便秘情况恶化。畏光、尿潴留和面部潮红是药物的其他副作用。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
报告细分和范围:
流涎症治疗市场根据医疗治疗和最终用户分为两类。根据医疗治疗,市场分为药物治疗、放射治疗和其他。根据最终用户,流涎症治疗市场分为医院、专科诊所、家庭护理机构和其他。根据地理位置,流涎症治疗市场分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、意大利、英国、西班牙和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太地区其他地区)、中东和非洲(沙特阿拉伯、阿联酋、南非和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)
节段分析:
根据药物治疗,流涎症治疗市场细分为药物治疗、放射治疗和其他。2022 年,药物治疗领域占据了最大的市场份额。此外,该领域预计将在 2022-2030 年期间录得最高复合年增长率。疫苗可提供针对特定传染病的主动获得性免疫。在多个独立临床试验中,苯扎托品、格隆溴铵、东莨菪碱和肉毒杆菌毒素等药物治疗已被证明可有效治疗流涎症。药物通过口服或肠外给药。肉毒杆菌毒素在解剖外部触诊或超声引导下注射到唾液腺中。
按最终用户划分,流涎症治疗市场分为医院、专科诊所、家庭护理机构和其他。医院部门在 2022 年占据了最大的市场份额,预计在 2022-2030 年期间将创下最高复合年增长率。流涎症的治疗是在医院通过适当的治疗和运动疗法进行的,由经验丰富的跨学科医疗专家(包括物理治疗师和神经病学专家)提供帮助。
区域分析:
根据地区,流涎治疗市场分为五个主要地区——北美、欧洲、亚太、南美和中美以及中东和非洲。北美市场分析主要集中在三个主要国家——美国、加拿大和墨西哥。预计亚太地区将在 2022-2030 年期间创下流涎治疗市场的最高复合年增长率。推动流涎治疗市场增长的主要因素包括政府不断采取措施提高人们对这种疾病的认识、该地区不断增加的研发活动、市场参与者越来越多地转向提供更好的治疗方案。
流涎症治疗市场机会:
改进的流涎治疗基因疗法将在预测期内为流涎治疗市场提供有利可图的机会
据美国国立卫生研究院称,一项实验表明,基因治疗可以安全地在人类唾液腺中进行。该基因帮助唾液腺细胞将唾液分泌到口腔中。Ad5 介导的 N-myc 下游调节基因 2 (NDRG2) 转移可纠正唾液腺功能减退。此外,对于患有唾液腺功能减退且不想冒雌激素补充疗法副作用风险的绝经后妇女,使用 NDRG2 基因转移可能具有临床意义。因此,上述因素预计将在未来几年为流涎治疗市场提供机会。
流涎症治疗市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响流涎治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的流涎治疗市场细分和地理位置。
- 获取流涎治疗市场的区域特定数据
流涎治疗市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 6.9506亿美元 |
2030 年市场规模 | 10.4237亿美元 |
全球复合年增长率(2022 - 2030 年) | 5.2% |
史料 | 2020-2022 |
预测期 | 2022-2030 |
涵盖的领域 | 通过药物治疗
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
市场参与者密度:了解其对商业动态的影响
流涎治疗市场正在快速增长,这得益于终端用户需求的不断增长,这些需求源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在流涎症治疗市场运营的主要公司有:
- 辉瑞公司
- F. 霍夫曼-罗氏有限公司
- 迈兰公司
- 费森尤斯卡比公司
- Hikma Pharmaceuticals PLC
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 获取流涎治疗市场主要参与者概览
竞争格局和重点公司:
辉瑞公司、罗氏公司、迈兰公司、费森尤斯卡比公司、Hikma Pharmaceuticals PLC、诺华公司、梯瓦制药工业有限公司、百时美施贵宝公司、葛兰素史克公司、拜耳公司和太阳制药工业有限公司是全球流涎治疗市场的主要参与者。这些公司专注于开发新技术、改进现有产品和扩大地理覆盖范围,以满足全球日益增长的消费者需求并扩大其专业产品组合范围。在全球流涎治疗市场运营的公司正在实施各种无机和有机战略。下面提到了其中一些:
- 2021 年 8 月,Merz 集团旗下企业、神经毒素领域的领导者 Merz Therapeutics 获得了欧盟层面的 XEOMIN 使用许可,用于对因神经发育障碍/神经系统疾病导致的 2 至 17 岁、体重 ≥ 12 公斤的儿童和青少年慢性流涎症进行对症治疗。美国食品药品监督管理局于 2020 年 12 月批准了该药物,俄罗斯联邦医疗监督局于 2021 年 8 月批准了该药物。
- 2023年2月,专门生产儿童药物的制药公司Proveca Pharma Ltd向法国因慢性神经系统疾病而患有严重流涎症的儿童提供了Sialanar(格隆溴铵)。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The term "hypersalivation," or "sialorrhea," refers to excessive saliva production. When individuals have extensive posterior saliva leakage down their tracheas instead of being routinely swallowed, it is known as posterior sialorrhea. Patients with anterior sialorrhea experience excessive anterior or forward salivation, also known as drooling, onto their faces and clothing, which makes it difficult for them to maintain hygiene, take care of their skin, and interact with others. Aspiration, a long-term lung irritation caused by this, can occasionally lead to pneumonia.
Based on medical therapy, the pharmacologic therapy segment took the forefront leaders in the worldwide market by accounting largest share in 2022 and is expected to continue to do so till the forecast period.
Increasing prevalence of neurodegenerative disorders and various treatment options available for sialorrhea treatment are the most significant factors responsible for the overall market growth.
Pfizer Inc, F. Hoffmann-La Roche Ltd, Mylan N.V., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Novartis AG, Teva Pharmaceutical Industries Ltd., Bristol Myers Squibb Company, GSK Plc., Bayer AG, and Sun Pharmaceutical Industries Ltd among others are among the leading companies operating in the sialorrhea treatment market.
Sialorrhea treatment market is segmented by regions comprising of North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.
The hospitals segment dominated the sialorrhea treatment market and accounted for the largest market share in 2022.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Sialorrhea Treatment Market
- Pfizer Inc
- F. Hoffmann-La Roche Ltd
- Mylan N.V.
- Fresenius Kabi AG
- Hikma Pharmaceuticals PLC
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Bristol Myers Squibb Company
- GSK Plc.
- Bayer AG
- Sun Pharmaceutical Industries Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.